Expertise: Clinical Development 75 results

Clinical Development

Celebrating World Cancer Day: An Interview with Leading Oncology Experts

Every year on February 4th, the world comes together to recognize World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC). This day unites individuals, communities, and organizations in the fight against cancer while raising awareness and promoting actions to reduce its global impact. For 2025, the theme “United by…

Clinical Development

Bringing an Oncology Asset to Market: In-House vs Outsource?

During the multifaceted journey of bringing a promising therapeutic to market, sponsors are faced with a critical choice—whether to manage asset development in-house or to outsource to a clinical research organization (CRO) partner. This decision can influence timelines, costs, control over the development process, and the likelihood of success. Understanding the pros and cons of…

Clinical Development

Sponsor Responsibilities Under ICH GCP E6: The Non-Negotiables for CRO Oversight

In the rapidly evolving landscape of clinical research, sponsors are under increasing pressure to conduct efficient, high-quality trials that meet stringent regulatory standards. The International Council for Harmonisation’s Good Clinical Practice (ICH GCP) E6 (R2) guidelines and the forthcoming E6 (R3) update outline the multifaceted responsibilities sponsors bear throughout the clinical trial process. Central to…